Amanta Healthcare Limited — PPTs, 05-08-2026: Investor Presentation

Here's a summary of Amanta Healthcare Limited's investor presentation, focusing on key insights for retail investors:

**1. Business Performance:**

Amanta Healthcare demonstrated a steady performance in Q1FY27, with revenues growing 5% YoY to ₹69 Cr. This growth was achieved on existing capacity, showcasing operational efficiency. The company maintained its EBITDA margins at 22% despite cost pressures, reflecting strong operational discipline.

**2. Growth Drivers or Strategy:**

Key growth drivers include market depth through complex dosages and niche molecules in areas like anti-infectives and respiratory care. Furthermore, strategic capacity expansion in high-margin SteriPort and SVP segments is underway, expected to commence from Q2FY27. The company is also focusing on cost optimization through a 10.8 MW solar captive power plant, which started contributing from Q1FY27 and is projected to save ₹9 Cr annually.

**3. Recent Developments:**

The captive solar power plant, a significant step towards cost reduction and ESG improvement, was commissioned in Q1FY27. Expansion of SteriPort and SVP capacities are on track for commencement in Q2FY27 and Q4FY27, respectively.

**4. Key Financial Metrics:**

Q1FY27 Revenue: ₹69 Cr (5% YoY growth)

Q1FY27 EBITDA: ₹15 Cr (5% margin)

Q1FY27 PAT: ₹3 Cr (4% margin)

Full Year FY26 Revenue: ₹288 Cr

Full Year FY26 PAT: ₹15 Cr

**5. Management Commentary / Outlook:**

The management anticipates that operations from capacity expansions will contribute to growth from Q2FY27 onwards. The company is prioritizing new product development to further enrich its portfolio and expects significant revenue growth and EBITDA margin expansion over the next two years. The company has also successfully reduced its debt-to-equity ratio significantly from 3.50x in FY23 to 1.06x in FY26, indicating improved financial health.